On 10 July, K2M announced that it has expanded its biologics portfolio with the launch of its Vesuvius Osteobiologic Systems and new additions to its Vikos Allograft Systems.
K2M is working with LifeNet Health, a leading allograft bio-implant and regenerative medicine company, to bring to market implants to enhance bone regeneration and osteoconductivity.
“K2M’s launch of Vesuvius and Vikos products is an exciting expansion to their biologics portfolio. Vesuvius and Vikos provide useful alternatives to the management of complex spinal surgical issues, and these unique products complement and enhance K2M’s already comprehensive and innovative spine portfolio,” said Paul Savas, K2M’s medical director for Tissue Products and orthopaedic surgeon in Williamsburg, USA.
“We are excited to further our relationship with LifeNet Health, a leader in the field, to dramatically grow our company’s presence in the US$1.8 billion US biologics sector and meet a significant demand for the high quality products that surgeons have come to expect from K2M,” said Eric Major, K2M’s president and CEO.
“Our ability to save lives and restore health depends on the grace and generosity of donors and their families,” said Doug Wilson, executive vice president of LifeNet Health. “We are fortunate to have available donations and we are honoring the gifts of donation and using them to their fullest extent. Launching these new biologic implants with K2M made sense because we were able to work with an organisation with a record of enabling healthcare professionals around the world to help more people.”
The Vesuvius systems are designed specifically to enhance bone regeneration after spine surgery and in a variety of configurations and sizes to meet surgeons’ clinical needs. Vesuvius Demineralized Fibers and Sponge are treated with LifeNet Health’s patented Allowash XG sterilisation process and PAD demineralisation technology to protect bone morphogenetic proteins (BMPs), while ensuring optimal osteoinductivity.
The LifeNet Health relationship also enabled K2M to extend its existing Vikos Cervical offering to include unicortical, tricortical, and iliac crest grafts, as well as add two new product lines, Vikos Void Fillers and Vikos Shafts. Vikos has been designed to enhance osteoconductivity after spine surgery.